Celltrion, Inc. v. Regeneron Pharmaceuticals, Inc. > Summary
Court Case Number IPR2023-00620
Filing Date Feb 28, 2023
Institution Decision Date Sep 1, 2023
Decision Date Sep 1, 2023
Court Patent Trial and Appeal Board
Status Institution Denied
Administrative JudgesSusan L. C. Mitchell, John G. New, Robert A. Pollock
Judge Writing the Final DecisionSusan L. C. Mitchell
Claims Challenged in the Petition: 1, 2, 3, 4
Petitioner
Patent Owner
Petitioner Attorneys
6Celltrion
Attorney Name: Lora M. Green
Gemini Law LLP
Celltrion
Attorney Name: David S. Kim
Gemini Law LLP
Celltrion
Attorney Name: Brigid M. Morris
Gemini Law LLP
Celltrion
Attorney Name: Robert Cerwinski
Gemini Law LLP
Celltrion
Attorney Name: Aviv Zalcenstein
Gemini Law LLP
Celltrion
Attorney Name: Franklin Chu
Gemini Law LLP
Patent Owner Attorneys
6Regeneron Pharmaceuticals
Attorney Name: Jessica C. Kaiser
Arnold & Porter Kaye Scholer
Regeneron Pharmaceuticals
Attorney Name: Elizabeth A. Long
Arnold & Porter Kaye Scholer
Regeneron Pharmaceuticals
Attorney Name: Matthew Wilk
Arnold & Porter Kaye Scholer
Regeneron Pharmaceuticals
Attorney Name: Victoria Reines
Arnold & Porter Kaye Scholer
Regeneron Pharmaceuticals
Attorney Name: Jeremy D. Cobb
Arnold & Porter Kaye Scholer
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 10406226 | Method of manufacturing VEGF antagonist fusion proteins | Sep 10, 2019 |
